Atlas market file · Equity · United States
U S Global Investors IncGROW
- Last close
- 3.1
- Change
- +0.00%
- 96-bar range
- 2.43 – 3.31
- As of
- 7 Aug 2026
U S Global Investors Inc is an investment advice issuer listed as GROW on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+22.05% over the window).
Source rail: Yahoo Finance chart API (GROW). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for GROW. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
GROW public profile
Investment advice issuer. U S Global Investors Inc is connected to current market context, cited company sources and its retained research file.
U S Global Investors Inc trades as GROW on NASDAQ. U S Global Investors Inc (GROW) has a latest verified close of 3.1, unchanged, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files GROW under USA Stocks for browsing.
What changed for U S Global Investors Inc today
U.S. Global Investors Inc (NASDAQ: GROW), the San Antonio-based investment adviser whose marketing still trades on the romance of gold and global luxury, has quietly reported that its net income for the quarter to 31 March 2026 was $2.7 million, a figure that sounds healthier than it feels once you see operating income parked at just $88,000. The company’s glossy fund literature still hawks exotic exposures-gold, luxury goods, global mandates-but the latest 10-Q shows a business whose operating engine is barely idling: net cash from operations clocked in at $519,000, while capex for the period was a trivial $40,000. The cash pile of $24.6 million is large relative to the operating footprint, yet the diluted earnings per share of $0.23 suggests shareholders are collecting change from a slot machine that pays out in dribs and drabs.
The firm’s product rail remains a collection of thematic funds-gold funds, luxury-goods funds, global funds-all marketed under the banner of “longstanding experience in global markets and specialized sectors.” The company’s FAQ and resource pages double down on the narrative, offering quizzes on famous American inventions and libraries of fund reports, while the SEC filings quietly reveal a firm whose operating income barely covers the cost of a decent corporate retreat. The contrast between the polished pitch and the prosaic P&L is now so stark that even the most loyal fund buyer might pause to wonder whether the “global” in “global markets” refers to the fund range or the reach of the firm’s imagination.
The numbers tell a clear story. For the three months to 31 March 2026, U.S. Global reported net income attributable to parent of $2.7 million, operating income of $88,000, assets of $48.9 million, liabilities of $2.9 million, and stockholders’ equity of $46.0 million. Cash and equivalents were $24.6 million, net cash from operations was $519,000, and capex was $40,000. Diluted EPS stood at $0.23 on 11.9 million shares. The company’s 10-Q for the quarter is the latest filed source, and the SEC filings index shows the firm has been unusually busy with updates this quarter, including restatements of EPS figures for both the quarter ended 31 March 2026 and Q3 2026, each time insisting the underlying results are unchanged.
If you’re shopping for a chart route, GROW trades on NASDAQ under ticker GROW; the SEC filings, company facts JSON, and submissions JSON are all public, but the company does not supply live price data or chart levels in its filings. The stock’s liquidity and recent price action are therefore outside the evidence pack, and any attempt to infer support or resistance would be speculation rather than sourcing. The filings themselves are the only verifiable ground here, and they show a firm whose polished platform contrasts with prosaic operating results. The recent EPS restatements are a reminder that even small corrections in reported figures can unsettle the narrative, especially when the operating engine is running so quietly.
What changed this week: the company completed the restatement of EPS for Q3 2026 and announced its intent to restate EPS for the quarter ended 31 March 2026, each time stating that the underlying financial results are unchanged. The filings also confirm operating income of $88,000 for the latest quarter, net income of $2.7 million, and diluted EPS of $0.23. The operating cash flow of $519,000 and capex of $40,000 reinforce that the business is not burning cash, but neither is it generating the kind of momentum you’d expect from a firm selling “exotic” global exposures. The resource listings and product pages remain unchanged in tone, still peddling the gold-and-luxury story while the P&L quietly ticks over.
What remains unproven: the evidence does not show revenue, segment-level performance, asset flows, or fund performance data. The filings do not parse fund-level AUM, expense ratios, or investor flows, so any claim about the health of the fund franchise would be conjecture. The company’s marketing rail-quizzes on American inventions, fund reports, and luxury-goods fund descriptions-is vivid but not financially probative. Until the firm discloses fund-level metrics or segment revenues, the operating story is limited to the corporate P&L and the restatement headlines, neither of which suggests a business on the march.
What would deepen the file next: a quarterly fund performance report, AUM disclosures, segment revenues for each fund strategy, and a clear explanation of the accounting adjustments that produced the EPS restatements. If the company were to publish a fund-by-fund breakdown with net flows and performance since inception, the narrative could shift from “polished platform versus prosaic P&L” to “evidence-based fund operator.” Until then, the file reads like a classic case of marketing flair outrunning operating oomph.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
GROW technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on GROW
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep GROW research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
GROW FAQ
What is U S Global Investors Inc (GROW)?U S Global Investors Inc (GROW) has a latest verified close of 3.1, unchanged, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed...
U S Global Investors Inc (GROW) has a latest verified close of 3.1, unchanged, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for GROW?U S Global Investors Inc (GROW) has a latest verified close of 3.1, unchanged, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources,...
U S Global Investors Inc (GROW) has a latest verified close of 3.1, unchanged, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files GROW under USA Stocks for browsing.
How often is the GROW page updated?The GROW public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The GROW public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for GROW?The GROW file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:GROW. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The GROW file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:GROW. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on GROW?Yes. The workstation can open GROW, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open GROW, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this GROW page investment advice?No. The GROW page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The GROW page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
GROW
Equity · evidence first